Diploma (LON:DPLM) Stock Passes Above Two Hundred Day Moving Average – What’s Next?

Diploma PLC (LON:DPLM)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 5,066.57 and traded as high as GBX 5,495. Diploma shares last traded at GBX 5,460, with a volume of 295,201 shares trading hands.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Shore Capital reissued a “hold” rating and issued a GBX 5,100 price objective on shares of Diploma in a research note on Thursday, July 17th. Berenberg Bank increased their price target on shares of Diploma from GBX 5,750 to GBX 6,350 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Royal Bank Of Canada upgraded shares of Diploma to an “outperform” rating and raised their price target for the stock from GBX 4,500 to GBX 6,000 in a report on Friday, October 3rd. Jefferies Financial Group upped their price objective on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the company a “hold” rating in a research note on Thursday, September 11th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 4,440 target price on shares of Diploma in a research report on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Diploma has a consensus rating of “Moderate Buy” and a consensus target price of GBX 5,365.

Diploma Trading Up 0.8%

The company has a 50 day moving average of GBX 5,423.05 and a 200 day moving average of GBX 5,066.57. The firm has a market cap of £7.38 billion, a P/E ratio of 44.29, a PEG ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.